Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4 studies found for:    04-21
Show Display Options
Rank Status Study
1 Active, not recruiting Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
Conditions: Myelodysplastic Syndromes;   MDS;   RAEB;   Chronic Myelomonocytic Leukemia
Intervention: Drug: ON 01910.Na
2 Completed Monitoring of Delayed Ischemia After Subarachnoid Hemorrhage
Condition: Subarachnoid Hemorrhage
Intervention:
3 Completed Topical Therapy for Prevention of Infections in Preterm Infants
Condition: Skin Diseases
Interventions: Drug: Aquaphor;   Drug: Sunflower Seed Oil
4 Completed Taxoprexin Treatment for Advanced Skin Melanoma
Condition: Metastatic Melanoma
Intervention: Drug: Taxoprexin

Indicates status has not been verified in more than two years